Header Logo

Connection

JENNIFER WARGO to Melanoma-Specific Antigens

Back to Details
This is a "connection" page, showing publications JENNIFER WARGO has written about Melanoma-Specific Antigens.
JENNIFER WARGO
Connection Strength
0.106
Melanoma-Specific Antigens
  1. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013 Mar 01; 19(5):1225-31.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.